Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(10):818-819;
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Brown, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, M. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 10, 818-819, May 19, 1999
© 1999 Oxford University Press

EDITORIALS

Cancer Patient Care in Clinical Trials Sponsored by the National Cancer Institute: What Does It Cost?

Martin L. Brown

Correspondence to: Martin L. Brown, Ph.D., Applied Research Branch, Cancer Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Executive Plaza North, Rm. 313, Bethesda, MD 20892-7344.

"What does it cost?" This has been the refrain reiterated with increasing intensity over the last decade on the issue of financial coverage of patient care for patient's enrolled in clinical trials sponsored by the National Cancer Institute (NCI). In the past, the answer to this question, to the frustration of health care payers and providers, has been, "We don't know."

In recent years, the financial coverage of patient care in clinical trials has become an urgent question because implicit subsidies available for support of clinical research in the past have been suppressed by various measures aimed at achieving global health care cost containment (1). The NCI, through its Office of Clinical Research Promotion, has been in the forefront of addressing this . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
D. P. Goldman, S. H. Berry, M. S. McCabe, M. L. Kilgore, A. L. Potosky, M. L. Schoenbaum, M. Schonlau, J. C. Weeks, R. Kaplan, and J. J. Escarce
Incremental Treatment Costs in National Cancer Institute-Sponsored Clinical Trials
JAMA, June 11, 2003; 289(22): 2970 - 2977.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. W.L. Yee, J. L. Pater, L. Pho, B. Zee, and L. L. Siu
Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?
J. Clin. Oncol., April 15, 2003; 21(8): 1618 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Roche, N. Paul, B. Smuck, M. Whitehead, B. Zee, J. Pater, M.-A. Hiatt, and H. Walker
Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group
J. Clin. Oncol., January 15, 2002; 20(2): 545 - 556.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. P. Goldman, M. L. Schoenbaum, A. L. Potosky, J. C. Weeks, S. H. Berry, J. J. Escarce, B. A. Weidmer, M. L. Kilgore, N. Wagle, J. L. Adams, et al.
Measuring the Incremental Cost of Clinical Cancer Research
J. Clin. Oncol., January 1, 2001; 19(1): 105 - 110.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. L. Bennett, T. J. Stinson, V. Vogel, L. Robertson, D. Leedy, P. O'Brien, J. Hobbs, T. Sutton, J. C. Ruckdeschel, T. N. Chirikos, et al.
Evaluating the Financial Impact of Clinical Trials in Oncology: Results From a Pilot Study From the Association of American Cancer Institutes/Northwestern University Clinical Trials Costs and Charges Project
J. Clin. Oncol., August 15, 2000; 18(15): 2805 - 2810.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
B. H. Fireman, L. Fehrenbacher, E. P. Gruskin, and G. T. Ray
Cost of Care for Patients in Cancer Clinical Trials
J Natl Cancer Inst, January 19, 2000; 92(2): 136 - 142.
[Abstract] [Full Text] [PDF]